Arcadia Biosciences (RKDA) Receives Daily Media Impact Score of 0.08
News stories about Arcadia Biosciences (NASDAQ:RKDA) have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm ranks the sentiment of media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Arcadia Biosciences earned a daily sentiment score of 0.08 on Accern’s scale. Accern also gave media headlines about the basic materials company an impact score of 45.5196719268341 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Arcadia Biosciences (NASDAQ RKDA) opened at $0.21 on Monday. Arcadia Biosciences has a twelve month low of $0.19 and a twelve month high of $1.50.
TRADEMARK VIOLATION WARNING: This piece was published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be accessed at https://www.watchlistnews.com/arcadia-biosciences-rkda-receives-daily-media-impact-score-of-0-08/1757393.html.
Arcadia Biosciences, Inc is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market.
Receive News & Ratings for Arcadia Biosciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.